Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03633929 · ClinicalTrials.gov registry record

mHealth for Patient Self-Management of Opioid Use Disorder

A clinical trial of Opioid Use Disorder, sponsored by Biomedical Development Corporation.

Completed
Registry status
19
Enrollment target
2
Study locations

NCT03633929 is a study of Opioid Use Disorder that has completed, run by Biomedical Development Corporation. The registered enrollment target is 19 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03633929, a study of Opioid Use Disorder, has completed, sponsored by Biomedical Development Corporation.

COMPLETED
Registry status
19 participants
Enrollment target
2
Study locations

Study Summary

Twenty individuals diagnosed with opioid use disorder (OUD) will be recruited to participate in a beta test to demonstrate feasibility of using an online tool to help them better self-manage their recovery.

Conditions Studied

Interventions

  • OTHER KIOS OUD

Study Locations (2)

Texas

  • Biomedical Development Corporation - San Antonio
  • Community Medical Services - San Antonio

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2020-07-08
Est. Completion 2020-09-30

What the Registry Record Tells You About NCT03633929

The ClinicalTrials.gov registry entry for NCT03633929 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The listed sponsor is Biomedical Development Corporation, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which KIOS OUD is the first listed.

NCT03633929 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03633929 about?

NCT03633929 is a clinical study titled "mHealth for Patient Self-Management of Opioid Use Disorder". Twenty individuals diagnosed with opioid use disorder (OUD) will be recruited to participate in a beta test to demonstrate feasibility of using an online tool to help them better self-manage their recovery.

What is the current status of trial NCT03633929?

This trial is currently completed. The enrollment target is 19 participants. The study started on 2020-07-08. Estimated completion is 2020-09-30.

What conditions does trial NCT03633929 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

What interventions are being tested in trial NCT03633929?

The interventions under investigation include: KIOS OUD (OTHER).

Who is sponsoring clinical trial NCT03633929?

This trial is sponsored by Biomedical Development Corporation, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03633929 being conducted?

This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.